Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
493(3):1342-1348
2013 Nov 16
N106 may serve as a good tool compound to validate a potential therapeutic strategy for treatment of heart failure
Furugaki K
is an uncompetitive antagonist of the N-Methyl-D-aspartate (NMDA) receptor
Motesanib (AMG-706) idipine 493(3):1342-1348Motesanib, also known as AMG 706, is the orally bioavailable multiple receptor tyrosine kinase inhibitor with potential antineoplastic activity. Motesanib selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet derived growth factor (PDGFR), kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation. Product information CAS Number: 453562 69 1 Molecular Weight: 373. 45 Formula: C22H23N5O Synonym:
US$ 24.99
US$ 18.99
US$ 74.99
US$ 49.99
US$ 19.99
US$ 33.99
US$ 54.99